相关实验视频
Updated: May 20, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
与肥胖相关的人类肝脏中药物代谢酶表达的改变
Katarzyna Kosicka-Noworzyń1, Aleksandra Romaniuk-Drapała2, Yi-Hua Sheng3
1Department of Physical Pharmacy and Pharmacokinetics, Poznan University of Medical Sciences, Rokietnicka 3, Poznań 60-806, Poland; Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854, USA.
肥胖会影响肝脏的药物代谢酶,可能改变药物清除. 这项研究在肥胖个体中发现了ALDH3B1,PTGS1和CEL的显著基因表达变化,突出了对剂量重新评估的需要.
科学领域:
- 药理学和毒理学 药理学和毒理学
- 肝病学 肝病学是一种肝病学.
- 基因组学就是基因组学.
背景情况:
- 肥胖与影响肝功能和药物代谢的生理变化有关.
- 肥胖症中药物代谢的改变可能会增加药物相互作用的风险.
- 目前的药物剂量建议可能不适合肥胖个体.
研究的目的:
- 研究肥胖对肝脏药物代谢酶基因表达的影响.
- 为了识别特定的酶,其表达在肥胖中发生变化.
- 了解肥胖对药物剂量的药理动力学影响.
主要方法:
- 从32名死后捐赠者获得人肝样本,根据体重指数 (BMI) 分类为对照组和肥胖组.
- 168种药物代谢酶的基因表达分析使用实时定量PCR进行.
- 统计分析发现,对照组和肥胖组之间的酶表达有显著差异.
主要成果:
- 肥胖与肝脏药物代谢酶的基因表达改变有关.
- 与对照组相比,在肥胖组中观察到ALDH3B1,PTGS1和CEL的统计学上显著的上调.
- 其他几种潜在差异被发现,但没有达到统计学意义.
结论:
- 肥胖严重影响特定肝脏药物代谢酶的基因表达.
- 观察到的ALDH3B1,PTGS1和CEL的变化可能会导致肥胖患者的药物药理学变化.
- 需要进一步的蛋白质和功能研究来阐明这些发现对蛋白质水平的影响和功能后果.
更多相关视频
10:17An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
Published on: April 26, 2019
08:04Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
相关概念视频
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Drug Biotransformation: Overview
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
The drug's acidity or basicity is essential in...
Cell Specific Gene Expression
Drug Metabolism: Phase I Reactions
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...